Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine efficacy and parasite clearance in children with uncomplicated falciparum malaria in Nchelenge District, Zambia
PACTR201905783261453Completed
- Sponsor
- Macha Research Trust
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of artemether + lumefantrine in Malaria, sponsored by Macha Research Trust. Primary endpoint: Therapeutic response. Started Dec 2014; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR201905783261453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201905783261453.